BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 25, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Sativex regulatory update

GW Pharmaceuticals said the Czech Republic approved Sativex to treat spasticity due to multiple sclerosis (MS). In March, Sativex was recommended for approval in six countries, including the Czech Republic, under the EU Mutual Recognition Procedure (see BioCentury,...

Read the full 166 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >